Skip to main content

Table 3 Comparison of Treg subpopulations, LAP+CD11b+ monocytes, and TGF-β concentrations in proliferative and secretory phases (mean ± SD) between endometriosis and control groups

From: Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis

Peritoneal fluid

Proliferative

rTregs (%)

P

eTregs (%)

P

nonTregs (%)

P

LAP+CD11b + Macrophages

P

TGF-β

P

 Endometriosis (n = 12)

0.73 ± 0.56

< 0.05

3.9 ± 1.7

< 0.05

7.7 ± 2.7

ns

13.0 ± 14.4

< 0.05

1.12 ± 0.57

< 0.05

 Control (n = 10)

0.47 ± 0.60

2.2 ± 1.5

5.8 ± 2.1

80.0 ± 19.7

0.85 ± 0.26

Secretory

rTregs (%)

P

eTregs (%)

P

nonTregs (%)

P

LAP+CD11b + Macrophages

P

TGF-β

P

 Endometriosis (n = 16)

0.82 ± 0.75

< 0.05

3.1 ± 2.8

< 0.05

6.0 ± 3.0

ns

12.1 ± 16.4

< 0.05

1.09 ± 0.32

< 0.05

 Control (n = 10)

0.30 ± 0.24

1.8 ± 1.3

8.6 ± 1.6

81.3 ± 17.3

0.79 ± 0.26

Peripheral blood

Proliferative

rTregs (%)

P

eTregs (%)

P

nonTregs (%)

P

LAP+CD11b + Monocytes

P

  

 Endometriosis (n = 12)

1.3 ± 0.61

ns

1.2 ± 2.2

ns

2.4 ± 1.9

ns

83.5 ± 16.7

ns

  

 Control (n = 10)

1.3 ± 2.6

1.2 ± 0.8

4.4 ± 2.6

79.2 ± 19.1

  

Secretory

rTregs (%)

P

eTregs (%)

P

nonTregs (%)

P

LAP+CD11b + Monocytes

P

  

 Endometriosis (n = 12)

2.1 ± 1.6

ns

0.9 ± 1.0

ns

3.0 ± 1.8

ns

80.3 ± 19.7

ns

  

 Control (n = 10)

0.8 ± 2.8

0.8 ± 0.4

3.9 ± 2.2

85.9 ± 11.5

  
  1. Differences between groups were analyzed by Mann-Whitney U-tests. ns, not significant